These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21059209)

  • 1. Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma.
    Lu YW; Li J; Guo WJ
    J Exp Clin Cancer Res; 2010 Nov; 29(1):143. PubMed ID: 21059209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.
    Silva J; García JM; Peña C; García V; Domínguez G; Suárez D; Camacho FI; Espinosa R; Provencio M; España P; Bonilla F
    Clin Cancer Res; 2006 Dec; 12(23):6929-36. PubMed ID: 17145810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of BMI-1 and Mel-18 in breast tissue--a diagnostic marker in patients with breast cancer.
    Riis ML; Lüders T; Nesbakken AJ; Vollan HS; Kristensen V; Bukholm IR
    BMC Cancer; 2010 Dec; 10():686. PubMed ID: 21162745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma.
    Lv J; Cao XF; Ji L; Zhu B; Wang DD; Tao L; Li SQ
    Med Oncol; 2012 Mar; 29(1):151-60. PubMed ID: 21259057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
    Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
    Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells.
    Guo WJ; Zeng MS; Yadav A; Song LB; Guo BH; Band V; Dimri GP
    Cancer Res; 2007 Jun; 67(11):5083-9. PubMed ID: 17545584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of Bmi-1 mRNA expression with differentiation, metastasis and prognosis of gastric carcinoma].
    Huang KH; Liu JH; Li XX; Song LB; Zeng MS
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):973-5. PubMed ID: 17666329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bmi-1 is critical for the proliferation and invasiveness of gastric carcinoma cells.
    Li W; Li Y; Tan Y; Ma K; Cui J
    J Gastroenterol Hepatol; 2010 Mar; 25(3):568-75. PubMed ID: 19968751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer.
    Zhang XW; Sheng YP; Li Q; Qin W; Lu YW; Cheng YF; Liu BY; Zhang FC; Li J; Dimri GP; Guo WJ
    Mol Cancer; 2010 Feb; 9():40. PubMed ID: 20170541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Bmi-1 is a prognostic marker in bladder cancer.
    Qin ZK; Yang JA; Ye YL; Zhang X; Xu LH; Zhou FJ; Han H; Liu ZW; Song LB; Zeng MS
    BMC Cancer; 2009 Feb; 9():61. PubMed ID: 19228380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
    Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
    Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic importance of overexpression of Bmi-1 mRNA in early breast cancers.
    Saeki M; Kobayashi D; Tsuji N; Kuribayashi K; Watanabe N
    Int J Oncol; 2009 Sep; 35(3):511-5. PubMed ID: 19639171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bmi-1 expression predicts prognosis for patients with gastric carcinoma.
    Liu JH; Song LB; Zhang X; Guo BH; Feng Y; Li XX; Liao WT; Zeng MS; Huang KH
    J Surg Oncol; 2008 Mar; 97(3):267-72. PubMed ID: 18041745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinicopathological significance of Bmi-1 expression in pathogenesis and progression of gastric carcinomas.
    Lu H; Sun HZ; Li H; Cong M
    Asian Pac J Cancer Prev; 2012; 13(7):3437-41. PubMed ID: 22994774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of B-cell-specific Moloney murine leukemia virus integration site 1 mRNA and protein in gastric cancer.
    Liu PW; Lin Y; Chen XY
    J Dig Dis; 2014 Apr; 15(4):166-73. PubMed ID: 24393364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between expression of gastrokine 1 and clinicopathological characteristics in gastric cancer patients.
    Xiao JW; Chen JH; Ren MY; Tian XB; Wang CS
    Asian Pac J Cancer Prev; 2012; 13(11):5897-901. PubMed ID: 23317277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.